Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1991;17:141-150

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, R. M.
Right arrow Articles by Triggle, C. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, R. M.
Right arrow Articles by Triggle, C. R.

Hypertension, Vol 17, 141-150, Copyright © 1991 by American Heart Association


ARTICLES

Prevention of hypertension and vascular changes by captopril treatment

RM Lee, KH Berecek, J Tsoporis, R McKenzie and CR Triggle
Department of Anaesthesia, McMaster University, Hamilton, Ontario, Canada.

Treatment of female spontaneously hypertensive rats (SHR) and control Wistar-Kyoto (WKY) rats with captopril was carried out by the addition of the drug in the drinking water throughout pregnancy and lactation and after weaning. At 28 weeks of age, average systolic blood pressure of treated SHR was 113 +/- 3 mm Hg, which was below that of control SHR (188 +/- 3 mm Hg) and WKY rats (124 +/- 3 mm Hg). Body weight and heart rate of the SHR were not affected by the treatment. Tissue level of catecholamines was increased by captopril treatment in the superior cervical ganglia but remained unchanged in the plasma, heart, mesenteric arteries, and the adrenal glands of both SHR and WKY rats. Left ventricular weight, wall thickness, and internal diameter of the left ventricle in the SHR were reduced by the treatment. Morphometric measurements of the mesenteric arteries showed that vascular alterations present in the control SHR were prevented by the treatment. In the superior mesenteric artery and large mesenteric artery, smaller lumen size at maximal relaxation found in the control SHR was normalized to the level of the WKY rats. Hypertrophy of the medial wall in the superior mesenteric, large and small mesenteric arteries, and an increase in the number of smooth muscle cell layers in the large mesenteric artery of the SHR were prevented by the treatment. Perfusion study of the mesenteric vascular bed showed that reactivity of these vessels to norepinephrine was reduced, and sensitivity to norepinephrine (as determined by the effective dose that causes 50% of maximal response) was increased in the SHR by captopril treatment. Sensitivity of the tail artery in response to norepinephrine was not altered by the treatment. We conclude that long-term treatment with captopril of SHR before and after birth prevented the development of hypertension, structural and functional alterations of the mesenteric arteries, and cardiac hypertrophy.


This article has been cited by other articles:


Home page
J DAIRY SCIHome page
A. Geerlings, I. C. Villar, F. H. Zarco, M. Sanchez, R. Vera, A. Z. Gomez, J. Boza, and J. Duarte
Identification and characterization of novel Angiotensin-converting enzyme inhibitors obtained from goat milk.
J Dairy Sci, September 1, 2006; 89(9): 3326 - 3335.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. A. F. De Godoy and S. Rattan
Angiotensin-Converting Enzyme and Angiotensin II Receptor Subtype 1 Inhibitors Restitute Hypertensive Internal Anal Sphincter in the Spontaneously Hypertensive Rats
J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 725 - 734.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
C. Rugale, M. Cordaillat, A. Mimran, and B. Jover
Prevention and Reversal by Enalapril of Target Organ Damage in Angiotensin II Hypertension
Journal of Renin-Angiotensin-Aldosterone System, September 1, 2005; 6(3): 154 - 160.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Miquel, R. Gisbert, E. Serna, F. Perez-Vizcaino, E. Anselmi, M. A. Noguera, M. D. Ivorra, and M. P. D'Ocon
Acute and Chronic Captopril, but Not Prazosin or Nifedipine, Normalize Alterations in Adrenergic Intracellular Ca2+ Handling Observed in the Mesenteric Arterial Tree of Spontaneously Hypertensive Rats
J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 359 - 367.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Julius, S. Nesbitt, B. Egan, N. Kaciroti, M. A. Schork, M. Grozinski, E. Michelson, and for the TROPHY study group
Trial of Preventing Hypertension: Design and 2-Year Progress Report
Hypertension, August 1, 2004; 44(2): 146 - 151.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Gao, C. Zhu, and E. K. Jackson
alpha 2-Adrenoceptors Potentiate Angiotensin II- and Vasopressin-Induced Renal Vasoconstriction in Spontaneously Hypertensive Rats
J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 581 - 586.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. K. Jackson, W. A. Herzer, C. K. Kost Jr, and S. J. Vyas
Enhanced Interaction Between Renovascular {alpha}2-Adrenoceptors and Angiotensin II Receptors in Genetic Hypertension
Hypertension, September 1, 2001; 38(3): 353 - 360.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. S. Reddi, V. R. Nimmagadda, and R. Arora
Effect of Antihypertensive Therapy on Renal Artery Structure in Type 2 Diabetic Rats With Hypertension
Hypertension, May 1, 2001; 37(5): 1273 - 1278.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. W. CARLEY, K. BERECEK, A. VIDENOVIC, and M. RADULOVACKI
Sleep-disordered Respiration in Phenotypically Normotensive, Genetically Hypertensive Rats
Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1474 - 1479.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
W. P. Anderson, M. M. Kett, K. M. Stevenson, A. J. Edgley, K. M. Denton, and S. M. Fitzgerald
Renovascular Hypertension : Structural Changes in the Renal Vasculature
Hypertension, October 1, 2000; 36(4): 648 - 652.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. Zicha and J. Kunes
Ontogenetic Aspects of Hypertension Development: Analysis in the Rat
Physiol Rev, October 1, 1999; 79(4): 1227 - 1282.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. A. W. Dukacz, M. A. Adams, and R. L. Kline
Short- and long-term enalapril affect renal medullary hemodynamics in the spontaneously hypertensive rat
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 1999; 276(1): R10 - R16.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Otsuka, M. Sugano, N. Makino, S. Sawada, T. Hata, and Y. Niho
Interaction of mRNAs for Angiotensin II Type 1 and Type 2 Receptors to Vascular Remodeling in Spontaneously Hypertensive Rats
Hypertension, September 1, 1998; 32(3): 467 - 472.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
U. Onaka, K. Fujii, I. Abe, and M. Fujishima
Antihypertensive Treatment Improves Endothelium-Dependent Hyperpolarization in the Mesenteric Artery of Spontaneously Hypertensive Rats
Circulation, July 14, 1998; 98(2): 175 - 182.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Bergstrom, I. Johansson, K. M. Stevenson, M. M. Kett, and W. P. Anderson
Perindopril Treatment Affects Both Preglomerular Renal Vascular Lumen Dimensions and In Vivo Responsiveness to Vasoconstrictors in Spontaneously Hypertensive Rats
Hypertension, April 1, 1998; 31(4): 1007 - 1013.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. G. Dickhout and R. M. K. W. Lee
Blood pressure and heart rate development in young spontaneously hypertensive rats
Am J Physiol Heart Circ Physiol, March 1, 1998; 274(3): H794 - H800.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Lu, H. Yang, and M. K. Raizada
Attenuation of ANG II actions by adenovirus delivery of AT1 receptor antisense in neurons and SMC
Am J Physiol Heart Circ Physiol, February 1, 1998; 274(2): H719 - H727.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
L. K. Gillies, M. Lu, H. Wang, and R. M. K. W. Lee
AT1 Receptor Antagonist Treatment Caused Persistent Arterial Functional Changes in Young Spontaneously Hypertensive Rats
Hypertension, December 1, 1997; 30(6): 1471 - 1478.
[Abstract] [Full Text]


Home page
StrokeHome page
S. Nag and D. W. Kilty
Cerebrovascular Changes in Chronic Hypertension : Protective Effects of Enalapril in Rats
Stroke, May 1, 1997; 28(5): 1028 - 1034.
[Abstract] [Full Text]


Home page
HypertensionHome page
R. S. Cunha, H. Dabire, I. Bezie, A. M. Weiss, K. Chaouche-Teyara, S. Laurent, M. E. Safar, and P. Lacolley
Mechanical Stress of the Carotid Artery at the Early Phase of Spontaneous Hypertension in Rats
Hypertension, April 1, 1997; 29(4): 992 - 998.
[Abstract] [Full Text]


Home page
HypertensionHome page
K. Skov, J. Fenger-Gron, and M. J. Mulvany
Effects of an Angiotensin-Converting Enzyme Inhibitor, a Calcium Antagonist, and an Endothelin Receptor Antagonist on Renal Afferent Arteriolar Structure
Hypertension, September 1, 1996; 28(3): 464 - 471.
[Abstract] [Full Text]


Home page
HypertensionHome page
M. Notoya, M. Nakamura, and K. Mizojiri
Effects of Lisinopril on the Structure of Renal Arterioles
Hypertension, March 1, 1996; 27(3): 364 - 370.
[Abstract] [Full Text]


Home page
HypertensionHome page
D. Rizzoni, M. Castellano, E. Porteri, G. Bettoni, M. L. Muiesan, A. Cinelli, and E. A. Rosei
Effects of Low and High Doses of Fosinopril on the Structure and Function of Resistance Arteries
Hypertension, July 1, 1995; 26(1): 118 - 123.
[Abstract] [Full Text]


Home page
HypertensionHome page
M. M. Kett, D. Alcorn, J. F. Bertram, and W. P. Anderson
Enalapril Does Not Prevent Renal Arterial Hypertrophy in Spontaneously Hypertensive Rats
Hypertension, March 1, 1995; 25(3): 335 - 342.
[Abstract] [Full Text]


Home page
HypertensionHome page
K. Komatsu, E. D. Frohlich, H. Ono, Y. Ono, A. Numabe, and G. W. Willis
Glomerular Dynamics and Morphology of Aged Spontaneously Hypertensive Rats : Effects of Angiotensin-Converting Enzyme Inhibition
Hypertension, February 1, 1995; 25(2): 207 - 213.
[Abstract] [Full Text]